STUDYING ATRIAL FIBRILLATION ON THE BASIS OF THE “PROFILE” REGISTRY

Aim. To research the prevalence of atrial fibrillation (AF) and to compare the clinical characteristics of the patients to those without AF.Material and methods. At the moment of cross-section the Profile Study included 671 patients with various cardiovascular diseases, those who consulted at the Pr...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. Yu. Martsevich, A. R. Navasardian, N. P. Kutishenko, L. Yu. Drozdova, A. V. Zakharova, N. V. Kiseleva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2014-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atrial fibrillation clinical properties registry
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/21
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE EVALUATION OF ANTITHROMBOTIC TREATMENT PRESCRIPTION DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION BY THE DATA OF PROFILE REGISTRY
by: S. Yu. Martsevich, et al.
Published: (2015-02-01)

Typical profile of a patient with atrial fibrillation in the Russian population based on medical registries. A systematic review
by: E. V. Stepina, et al.
Published: (2024-10-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

CRYOABLATION IN ATRIAL FIBRILLATION: RATIONALE OF THE NATIONAL PROSPECTIVE REGISTRY AND PRELIMINARY RESULTS
by: E. N. Mikhailov, et al.
Published: (2018-08-01)

CLINICAL PORTRAIT OF THE ATRIAL FIBRILLATION PATIENT IN Russian FEDERATION. DATA FROM THE GLOBAL REGISTRY Gloria AF
by: E. V. Shlyakhto, et al.
Published: (2017-10-01)

Pulmonary embolism and atrial fibrillation: analysis of data from the SIRENA Russian registry
by: E. Kh. Alieva, et al.
Published: (2022-08-01)

CLINICAL CHRACTERISTICS OF PATIENTS AND RESULTS OF CATHETER ABLATION IN ATRIAL FIBRILLATION IN RUSSIA: SUBANALYSIS OF THE EUROPEAN REGISTRY 2012-2016
by: E. N. Mikhailov, et al.
Published: (2018-08-01)

Clinical performance of the atrial fibrillation in the Russian population depending on the antithrombotic therapy: findings from the GLORIA-AF registry phase 2
by: E. V. Shlyakhto, et al.
Published: (2020-12-01)

Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries)
by: M. M. Loukianov, et al.
Published: (2020-12-01)

PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY)
by: M. N. Valiakhmetov, et al.
Published: (2017-09-01)

COMPARATIVE CHARACTERISTICS OF MULTIMORBIDITY, DRUG TREATMENT AND OUTCOMES IN POSTSTROKE PATIENTS WITH ATRIAL FIBRILLATION AND WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION (REGISTRY REGION DATA)
by: E. Yu. Okshina, et al.
Published: (2020-01-01)

Patients with atrial fibrillation after discharge from a multidisciplinary hospital: analysis of death risk and its causes based on 10-year follow-up data
by: M. M. Luk'yanov, et al.
Published: (2025-02-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights from a real-world registry
by: Mustafa Yildirim, et al.
Published: (2025-02-01)

PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
by: V. P. Mikhin, et al.
Published: (2017-05-01)

MANAGEMENT AND OUTCOMES IN ACUTE CORONARY SYNDROME WITH ATRIAL FIBRILLATION IN “NON-INVASIVE” CLINIC
by: A. D. Erlikh, et al.
Published: (2017-02-01)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015-09-01)

ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC
by: E. V. Stepina, et al.
Published: (2017-05-01)

The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries)
by: M. M. Loukianov, et al.
Published: (2019-09-01)

OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. M. Loukianov, et al.
Published: (2015-09-01)

Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries)
by: M. M. Loukianov, et al.
Published: (2021-11-01)

Adherence to Atrial Fibrillation (AF) Better Care (ABC) pathway and adverse clinical outcomes in patients with atrial fibrillation
by: Mohammad Ammar Hakim Osman, et al.
Published: (2025-08-01)

AN OBESE PATIENT “PORTRAIT” BY THE RESULTS OF OUTPATIENT CARDIOVASCULAR REGISTRY “PROFILE”
by: A. V. Zakharova, et al.
Published: (2016-08-01)

DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA)
by: M. M. Loukianov, et al.
Published: (2015-09-01)

PRESCRIPTION OF MEDICATIONS INFLUENCING PROGNOSIS IN ATRIAL FIBRILLATION WITH ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, CHRONIC HEART FAILURE, BY THE REGISTRY REKVAZA-CLINIC
by: E. V. Stepina, et al.
Published: (2017-04-01)

Clinical analysis of atrial fibrillation in pregnant women
by: H. F. Zhang, et al.
Published: (2020-04-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Heart failure and atrial fibrillation: updates and perspectives
by: V. N. Larina, et al.
Published: (2022-08-01)

THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER
by: S. Y. Martsevich, et al.
Published: (2015-09-01)

Real-world antithrombotic strategies in patients with atrial fibrillation and recently developed acute coronary syndrome
by: Hiroshi Iwata, et al.
Published: (2025-03-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes
by: M. M. Loukianov, et al.
Published: (2022-01-01)

Outcomes and Disease Management in Patients With Atrial Fibrillation ≥80 Years: Data From a Consecutive 11‐Year Real‐World Registry
by: Mustafa Yildirim, et al.
Published: (2025-02-01)

ATRIAL FIBRILLATION: FUNCTIONAL CLASSIFICATION
by: A. V. Germanov, et al.
Published: (2020-11-01)

Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries
by: Jose Maria Cepeda, et al.
Published: (2025-05-01)

IMPACT OF ATRIAL FIBRILLATION ON THE NEAR AND LONG-TERM PROGNOSIS OF LIFE AFTER ACUTE MYOCARDIAL INFARCTION. THE DATA OF THE LIS-1 STUDY (LYUBERTSY MORTALITY STUDY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study)
by: S. Yu. Martsevich, et al.
Published: (2020-01-01)

The Atrial FibriLlatiOn Registry (FLOW-AF): Patient Characteristics, Treatment Patterns, and Outcomes in Egypt
by: Mohamed Sobhy, et al.
Published: (2025-03-01)

SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT
by: E. A. Drozdova
Published: (2015-09-01)